𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of the G8 probe in predicting risk of Huntington disease

✍ Scribed by Maestri, Nancy E. ;Beaty, Terri H. ;Folstein, Susan E. ;Meyers, Deborah A. ;Opitz, John M. ;Reynolds, James F.


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
434 KB
Volume
28
Category
Article
ISSN
0148-7299

No coin nor oath required. For personal study only.

✦ Synopsis


Discovery of the linkage between the G8 probe and the gene for Huntington disease (HD) in families of varying ethnic origin, age-of-onset characteristics, and neurological symptomatology, makes it possible to use the G8 marker for presymptomatic testing of at-risk individuals. Risk estimates for such situations were calculated, using the program LIPED, with different G8 haplotype frequencies, different age-of-onset distributions, and varying amounts of family information. In the presence of untyped relatives, the resulting risk estimates can be extremely sensitive to G8 haplotype frequencies, and the higher risk was seen in individuals carrying rare haplotypes. Including haplotype information on distant relatives can also lead to greater variation in risk estimates. Changing the age-of-onset distribution had only a minimal effect on estimated risks, the largest effect was seen when informative at-risk sibs of the consultand were in their forties.


πŸ“œ SIMILAR VOLUMES


Use of the WISC in predicting organicity
✍ Harry S. Beck; Robert L. Lam πŸ“‚ Article πŸ“… 1955 πŸ› John Wiley and Sons 🌐 English βš– 412 KB πŸ‘ 2 views
Leflunomide use and the risk of intersti
✍ Samy Suissa; Marie Hudson; Pierre Ernst πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 66 KB πŸ‘ 1 views

## Abstract ## Objective Spontaneous reports of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) treated with leflunomide, a disease‐modifying antirheumatic drug (DMARD), have been appearing recently. To assess this risk, we conducted a population‐based epidemiologic stud